OccuLogix, Inc.

OccuLogix, Inc.

March 01, 2005 10:04 ET

OccuLogix to Present at SG Cowen & Co. 25th Annual Health Care Conference


NEWS RELEASE TRANSMITTED BY CCNMatthews

FOR: OCCULOGIX, INC.

NASDAQ SYMBOL: RHEO
TSX SYMBOL: RHE

MARCH 1, 2005 - 10:04 ET

OccuLogix to Present at SG Cowen & Co. 25th Annual
Health Care Conference

TORONTO, ONTARIO--(CCNMatthews - March 1, 2005) - OccuLogix, Inc.
(NASDAQ:RHEO)(TSX:RHE) announced today that it will present at the SG
Cowen & Co. 25th Annual Health Care Conference at The Boston Marriott
Copley Place on Wednesday, March 16 at 8:50 AM Eastern Time.

An audio Webcast will be available live and archived at the Investor
Relations section of www.occulogix.com.

About OccuLogix

OccuLogix is an ophthalmic therapeutic company founded to commercialize
innovative evidence based treatments for eye diseases, including
age-related macular degeneration. AMD is the leading cause of late onset
visual impairment and legal blindness in people over the age of 50.
OccuLogix's common shares trade on the NASDAQ National Market under the
symbol 'RHEO' and on the Toronto Stock Exchange under the symbol 'RHE'.

Forward Looking Statements

This press release may contain forward-looking statements. These
statements relate to future events and are subject to risks,
uncertainties and assumptions about the company. These statements are
only predictions based on our current expectations and projections about
future events. You should not place undue reliance on these statements.
Actual events or results may differ materially. Many factors may cause
our actual results to differ materially from any forward-looking
statement, including the factors detailed in our filings with the
Securities and Exchange Commission and Canadian regulatory authorities,
including our Registration Statement on Form S-1. We do not undertake to
update any forward-looking statements.

-30-

Contact Information

  • FOR FURTHER INFORMATION PLEASE CONTACT:
    OccuLogix, Inc.
    Stephen Kilmer
    VP, Corporate Affairs
    (905) 602-0887 ext. 3904
    stephen.kilmer@occulogix.com